Congenital aniridia keratopathy treatment;Manejo terapéutico de la queratopatía asociada a aniridia congénita

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 81, Issue 8, 2006, Pages 435-444

  Lopez Garcia J S ^a,d   Garcia Lozano I ^a,b   Rivas, L ^a,c   Martinez Garchitorena J ^a  

^a Central Red Cross Hospital   (Spain)

^b Visual Sciences Institute (INCIVI)   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL CENTRAL DE LA CRUZ ROJA   (Spain)

Author keywords

Aniridia; Autologous serum; Corneal epithelium; Dry eye; Limbal deficiency; Ocular surface

Indexed keywords

ANIRIDIA; CORNEA; CORNEA DISEASE; CORNEA TRANSPLANTATION; HUMAN; PATHOLOGY; REVIEW;

ANIRIDIA; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; HUMANS;

EID: 33750959923     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Zolog I, Belengeanu V, Marinca S, Soim A. Familial congenital aniridia. Oftalmologia 1997; 41: 326-328.
2. Ndoye Roth PA, de Medeiros Quenum ME, Wane Khouma AM, Dieng M, Ndiaye PA, Diane MH, et al. Aniridia: five case studies. J Fr Ophthalmol 2005; 28: 845-849.
3. Nishida K, Kinoshita S, Ohashi Y, Kuwayama Y, Yamamoto S. Ocular surface abnormalities in aniridia. Am J Ophthalmol 1995; 120: 368-375.
4. Hanson IM, Fletcher JM, Jordan T, Brown A, Taylor D, Adams RJ, et al. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat Genet 1994; 6: 168-173.
5. Jordan T, Hanson I, Zaletayev D, Hodgson S, Prosser J, Seawright A, et al. The human PAX6 gene is mutated in two patients with aniridia. Nat Gent 1992; 1: 328-332.
6. Chauhan BK, Yang Y, Cveklova K, Cvekl A. Functional properties of natural human PAX6 and PAX6(5a) mutants. Invest Ophthalmol Vis Sci 2004; 45: 385-392.
7. Callaerts P, Halder G, Gerhring WJ. PAX-6 in development and evolution. Annu Rev Neurosci 1997; 20: 483-532.
8. Collinson JM, Hill RE, West JD. Different roles for Pax6 in the optic vesicle and facial epithelium mediate early morphogenesis of the murine eye. Development 2000; 127: 945-956.
9. Collinson JM, Quinn JC, Buchanan MA, Kaufman MH, Wedden SE, West JD, et al. Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc Natl Acad Sci USA 2001; 98: 9688-9693.
10. Koroma BM, Yang JM, Sundin OH. The Pax-6 homeobox gene is expressed throughout the corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci 1997; 38: 108-120.
11. Collinson JM, Chanas SA, Hill RE, West JD. Corneal development, limbal stem cell function, and corneal epithelial cell migration in the Pax6 (±) mouse. Invest Ophthalmol Vis Sci 2004; 45: 1101-1108.
12. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001; 98: 3156-3161.
13. Ramaesh K, Dhillon B. Ex vivo expansion of corneal limbal epithelial/stem cells for corneal surface reconstruction. Eur J Ophthalmol 2003; 13: 515-524.
14. Liu CY, Zhu G, Westerhausen-Larson A, Converse R, Kao CW, Sun TT, et al. Cornea- specific expression of K12 keratin during mouse development. Curr Eye Res 1993; 12: 963-974.
15. Chiambaretta F, Blanchon L, Rabier B, Kao WW, Liu JJ, Dastugue B, et al. Regulation of corneal keratin-12 gene expression by the human Kruppel-like transcription factor 6. Invest Ophthalmol Vis Sci 2002; 43: 3422-3429.
16. Davis J, Duncan MK, Robison WG Jr, Piatigorsky J. Requirement for Pax6 in corneal morphogenesis: a role in adhesion. J Cell Sci 2003; 116: 2157-2167.
17. Ramaesh T, Collinson JM, Ramaesh K, Kaufman MH, West JD, Dhillon B. Corneal abnormalities in Pax6+/-small eye mice mimic human aniridia-related keratopathy. Invest Ophthalmol Vis Sci 2003; 44: 1871-1878.
18. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Retin Eye Res 1999; 18: 529-551.
19. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci 1995; 36: 809-819.
20. Sivak JM, Mohan R, Rinehart WB, Xu PX, Maas RL, Fini ME. Pax-6 expression and activity are induced in the reepithelializing cornea and control activity of the transcriptional promoter for matrix metalloproteinase gelatinase B. Dev Biol 2000; 222: 41-54.
21. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21: 1-14.
22. Brown D, Chwa M, Escobar M, Kenney MC. Characterization of the major matrix degrading metalloproteinase of human corneal stroma. Evidence for an enzyme/inhibitor complex. Exp Eye Res 1991; 52: 5-16.
23. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 2002; 277: 2065-2072.
24. Dua HS, Saini JS, Azuara-Blanco A, Gupta P. Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol 2000; 48: 83-92.
25. Nelson LB, Spaeth GL, Nowinski TS, Margo CE, Jackson L. Aniridia. A review. Surv Ophthalmol 1984; 28: 621-642.
26. Brandt JD, Casuso LA, Budenz DL. Markedly increased central corneal thickness: an unrecognized finding in congenital aniridia. Am J Ophthalmol 2004; 137: 348-350.
27. Gomes JA, Eagle RC Jr, Gomes AK, Rapuanao CJ, Cohen EJ, Laibson PR. Recurrent keratopathy after penetrating keratoplasty for aniridia. Cornea 1996; 15: 457-462.
28. Jastanciah S, Al-Rajhi AA. Association of aniridia and dry eyes. Ophthalmology 2005; 112: 1535-1540.
29. Rivas L, Murube J, Rivas A, Murube E. Estudio del ojo seco en pacientes con aniridia congénita, mediante citología de ipresión. Arch Soc Esp Oftalmol 2003; 78: 615-622.
30. Sridhar MS, Vemuganti GK, Bansal AK, Rao GN. Impression cytology-proven corneal stem cell deficiency in patients after surgeries involving the limbus. Cornea 2001; 20: 145-148.
31. Lavker RM, Tseng SC, Sun TT. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res 2004; 78: 433-446.
32. Buck RC. Ultrastructure of conjunctival epithelium replacing corneal epithelium. Curr Eye Res 1986; 5: 149-159.
33. Lauweryns B, van den Oord JJ, Missotten L. The transitional zone between limbus and peripheral cornea. An immunohistochemical study. Invest Ophthalmol Vis Sci 1993; 34: 1991-1999.
34. Tseng SC, Li DQ. Comparison of protein kinase C subtype expression between normal and aniridic human ocular surfaces: implications for limbal stem cell dysfunction in aniridia. Cornea 1996; 15: 168-178.
35. Lopez-Garcia JS, Rivas L, Garcia-Lozano I. Tratamiento de la insuficiencia limbal grave mediante cirugía combinada de trasplante de limbo y trasplante de membrana amniótica. Arch Soc Esp Oftalmol 2005; 80: 405-412.
36. Prabhasawat P, Tseng SC. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol 1997; 115: 1360-1367.
37. Dua HS, Azuara-Blanco A. Limbal stem cells of the corneal epithelium. Surv Ophthalmol 2000; 44: 415-425.
38. Tseng SC. Concept and application of limbal stem cells. Eye 1989; 3: 141-157.
39. Schlotzer-Schrehardt U, Kruse FE. Identification and characterization of limbal stem cells. Exp Eye Res 2005; 81: 247-264.
40. Ramaesh K, Ramaesh T, Dutton GN, Dhillon B. Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy. Int J Biochem Cell Biol 2005; 37: 547-557.
41. Tiller AM, Odenthal MT, Verbraak FD, Gortzak-Moorstein N. The influence of keratoplasty on visual prognosis in aniridia: a historical review of one large family. Cornea 2003; 22: 105-110.
42. Geerling G, Maclennan S, Hartwig D. Autologuos serum eye drops for ocular surface disorders. Br J Ophthalmol 2004; 88: 1467-1474.
43. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol 2005; 139: 242-246.
44. Poon AC, Gerling G, Dart JK, Fraenkel GE, Daniels JT. Autologuos serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85: 1188-1197.
45. Alvarado Valero MC, Martinez Toldos JJ, Borras Blasco J, Alminana Alminana A, Pérez Ramos JM. Tratamiento de los defectos epiteliales persistentes mediante suero autólogo. Arch Soc Esp Oftalmol 2004; 79: 537-542.
46. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologuos serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular disease. Br J Ophthalmol 2004; 88: 647-652.
47. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 70: 329-337.
48. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000; 20: 173-177.
49. Sonnenberg A, Calafat J, Janssen H, Daams H, van der Raaij-Helmer LM, Falcioni R, et al. Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggestin a major role in epidermal cell-basement membrane adhesion. J Cell Biol 1991; 113: 907-917.
50. Sridhar MS, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation in acute chemical and thermal injury. Am J Ophthalmol 2000; 130: 134-137.
51. Pires RT, Tseng SC, Prabhasawat P, Puangsricharern V, Maskin SL, Kim JC, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol 1999; 117: 1291-1297.
52. López-García JS, Rivas L, García-Lozano I. Trasplante de membrana amniótica en el tratamiento de la insuficiencia limbal moderada de pacientes con aniridia congénita. Arch Soc Esp Oftamol 2005; 80: 517-523.
53. Kruse FE, Reinhard T. Limbus transplantation for reconstruction of the ocular surface. Ophthalmologe 2001; 98: 818-831.
54. Holland EJ, Djalilian AR, Schwartz GS. Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 2003; 110: 125-130.
55. Meisler DM, Perez VL, Proudfit J. A device to facilitate limbal stem cell procurement from eye bank donor tissue for keratolimbal allograft procedures. Am J Ophthalmol 2005; 139: 212-214.
56. Sundmacher R, Reinhard T. Homologous lamellar central limbokeratoplasty in severe limbal stem cell deficiency. Klin Monatsbl Augenheilkd 1998; 213: 254-255.
57. Tseng SC, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without allografts for corneal surface reconstruction in patients with limbal stem cells deficiency. Arch Ophthalmol 1998; 116: 431-441.
58. Koizumi N, Inatomi T, Quantock AJ, Fullwood NJ, Dota A, Kinoshita S. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000; 19: 65-71.
59. Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 2000; 19: 421-426.
60. Tsai RJ, Li LM, Chen J. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000; 343: 86-93.
61. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 1998; 82: 235-240.
62. Nakamura T, Kinoshita S. Ocular surface reconstruction using cultivated mucosal epithelial stem cells. Cornea 2003; 22: S75-S80.
63. Arroyave CP, Scott IU, Gedde SJ, Parrish RK 2nd, Feuer WJ. Use of glaucoma drainage devices in the management of glaucoma associated with aniridia. Am J Ophthalmol 2003; 135: 155-159.
64. Chen TC, Walton DS. Goniosurgery for prevention of aniridic glaucoma. Arch Ophthalmol 1999; 117: 1144-1148.
65. Mavrikakis I, Casey JM. Phacoemulsification and endocapsular implantation of an artificial iris intraocular lens in traumatic cataract and aniridia. J Cataract Refrac Surg 2002; 28: 1088-1091.
66. Esquenazi S, Amador S. Bilateral cataract surgery combined with implantation of a brown diaphragm intraocular lens after trabeculectomy for congenital aniridia. Ophthalmic Surg Lasers 2002; 33: 514-517.
67. McCulley TJ, Mayer K, Dahr SS, Simpson J, Holland EJ. Aniridia and optic nerve hypoplasia. Eye 2005; 19: 762-764.
68. Menezo JL, Martinez-Costa R, Cisneros A, Desco MC. Implantation of iris devices in congenital and traumatic aniridias: surgery solutions and complications. Eur J Ophthalmol 2005; 15: 451-457.
69. Mavrikakis I, Mavrikakis E, Syam PP, Bell J, Casey JH, Casswell AG, et al. Surgical management of iris defects with prosthetic iris devices. Eye 2005; 19: 205-209.
70. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M. WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005; 116: 984-988.
71. Yasuda T, Kajimoto Y, Fujitani Y, Watada H, Yamamoto S, Watarai T, et al. PAX6 mutations as a genetic factor common to aniridia and glucose intolerance. Diabetes 2002; 51: 224-230.